Succinamide inhibitors of IL-1&bgr; converting enzyme

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1301-1308

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin–angiotensin system: a patent review

By Ferreira Anderson J   Bader Michael   Santos Robson AS  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 567-574

Informa Healthcare

Access to resources Recommend Favorite

Blockade of angiotensin converting enzyme but not of angiotensin AT 1 receptors improves glucose tolerance

By Chow L.   De Gasparo M.   Levens N.  

European Journal of Pharmacology, Vol. 319, Iss. 1, 1997-01 ,pp. : 77-83

Elsevier

Access to resources Recommend Favorite

Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT 1 receptors

By Chow L.   De Gasparo M.   Levens N.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 77-86

Elsevier

Access to resources Recommend Favorite

Increases of vascular endothelin-converting enzyme activity and endothelin-1 level on atherosclerotic lesions in hyperlipidemic rabbits

By Mitani H.   Takimoto M.   Bandoh T.   Kimura M.  

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 313-319

Elsevier

Access to resources Recommend Favorite